Healthcare -
Biotechnology - NASDAQ - US
$ 1.36
0 %
$ 87.4 M
Market Cap
-0.88
P/E
INZY - TOTAL EQUITY
Total Equity INZY - Inozyme Pharma, Inc.
140 M
LAST VALUE
13.39%
2 YEAR CAGR
64.72%
5 YEAR CAGR
0.00%
10 YEAR CAGR